0000000000113493

AUTHOR

E. Vivoli

showing 2 related works from this author

The proto-oncogene tyrosine-protein kinase MER as a novel modulator of fibrogenesis in NAFLD

2015

HepatologyOncogenebusiness.industryGastroenterologyCancer researchMedicinebusinessTyrosine-Protein Kinase MerDigestive and Liver Disease
researchProduct

Role of the receptor tyrosine kinase MER in the development of fibrosis in NAFLD

2015

s / Digestive and Liver Disease 47S (2015) e221–e225 e225 age of these patients was 61 years (SD 12); 53% were female. Compared to HCV patients without steatosis (3347), in patients with steatosis: BMI was ≥25 in 44% vs. 36% (p<0.05) and ≥30 in 18% vs 11% (p=0.05); F4/cirrhosis was present in 28% vs. 32% (p=ns). Among HCV patients with and without steatosis, similar distribution of HCV genotypes, transaminases and gamma GT levels, lipid pattern and other comorbidities were observed. Of 1295 patients with steatosis, in 167 (1.3%) liver biopsy was available and confirmed the NAFLD diagnosis. In this last group of patients the prevalence of diabetes and of cardiovascular disease were higher co…

medicine.medical_specialtyCirrhosisHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyDiseasemedicine.diseaseGastroenterologyLiver diseaseEndocrinologyFibrosisInternal medicineLiver biopsyDiabetes mellitusCohortmedicineSteatosisbusinessDigestive and Liver Disease
researchProduct